Free Trial Information
BioCentury | May 31, 2004
Finance

Ebb & Flow

...led by Innoven Partenaires. Other investors in the stroke company included OTC Asset Management; 3i; Genevest...
Read More
BioCentury | May 24, 2004
Financial News

Paion raises EUR 9.8 million

...led by Innoven Partenaires. Other investors in the stroke company included OTC Asset Management; 3i; Genevest...
Read More
BioCentury | Mar 15, 2004
Finance

'A' for effort

...Johnson & Johnson (JNJ); Janssen Paion $24.0 11/1/00 Cardiovascular; neurology Germany 3i; WestLB; Vertex Management; Genevest...
Read More
BioCentury | Jun 30, 2003
Emerging Company Profile

Corporate Profile

...Heidelberg Innovation, HBM BioVentures, Neomed, Venture Partners, Banque Cantonale Vaudoise Private Equity, New Medical Technologies, Genevest...
Read More
BioCentury | Sep 9, 2002
Finance

Ebb & Flow

...The fund will invest equally in biopharmaceutical companies, drug discovery plays and medical device companies. GeneVest...
Read More
BioCentury | Sep 3, 2002
Financial News

GeneVest to merge with Pinetree

GeneVest (TSE:GNV.U) - a publicly traded venture capital firm - will merge with Pinetree Capital (TSE:PNP) in a stock swap. Prior to the merger, GNV.U owned 15.8% of PNP, which invests across several technology sectors, including software,...
Read More
BioCentury | May 13, 2002
Emerging Company Profile

Corporate Profile

...of employees: 58 Funds raised: E33 million ($29.4 million) Investors: 3i; WestLB; Vertex Management Fund; Genevest/Neomed...
Read More
BioCentury | Apr 22, 2002
Finance

Ebb & Flow

...Cantonale Vaudoise Private Equity, joining existing investors New Medical Technologies (NMT), Venture Partners AG and Genevest...
Read More
BioCentury | Apr 22, 2002
Financial News

Axovan raises CHF30 million

...included Heidelberg Innovation; NeoMed; Banque Cantonale Vaudoise Private Equity; New Medical Technologies; Venture Partners; and Genevest...
Read More
BioCentury | Jul 14, 2000
Financial News

Axovan raises $4.9 million

...in a venture financing. Investors included Life Science Investments; NMT New Medical Technologies; Venture Partners; Genevest...
Read More
Items per page:
1 - 10 of 11
BioCentury | May 31, 2004
Finance

Ebb & Flow

...led by Innoven Partenaires. Other investors in the stroke company included OTC Asset Management; 3i; Genevest...
Read More
BioCentury | May 24, 2004
Financial News

Paion raises EUR 9.8 million

...led by Innoven Partenaires. Other investors in the stroke company included OTC Asset Management; 3i; Genevest...
Read More
BioCentury | Mar 15, 2004
Finance

'A' for effort

...Johnson & Johnson (JNJ); Janssen Paion $24.0 11/1/00 Cardiovascular; neurology Germany 3i; WestLB; Vertex Management; Genevest...
Read More
BioCentury | Jun 30, 2003
Emerging Company Profile

Corporate Profile

...Heidelberg Innovation, HBM BioVentures, Neomed, Venture Partners, Banque Cantonale Vaudoise Private Equity, New Medical Technologies, Genevest...
Read More
BioCentury | Sep 9, 2002
Finance

Ebb & Flow

...The fund will invest equally in biopharmaceutical companies, drug discovery plays and medical device companies. GeneVest...
Read More
BioCentury | Sep 3, 2002
Financial News

GeneVest to merge with Pinetree

GeneVest (TSE:GNV.U) - a publicly traded venture capital firm - will merge with Pinetree Capital (TSE:PNP) in a stock swap. Prior to the merger, GNV.U owned 15.8% of PNP, which invests across several technology sectors, including software,...
Read More
BioCentury | May 13, 2002
Emerging Company Profile

Corporate Profile

...of employees: 58 Funds raised: E33 million ($29.4 million) Investors: 3i; WestLB; Vertex Management Fund; Genevest/Neomed...
Read More
BioCentury | Apr 22, 2002
Finance

Ebb & Flow

...Cantonale Vaudoise Private Equity, joining existing investors New Medical Technologies (NMT), Venture Partners AG and Genevest...
Read More
BioCentury | Apr 22, 2002
Financial News

Axovan raises CHF30 million

...included Heidelberg Innovation; NeoMed; Banque Cantonale Vaudoise Private Equity; New Medical Technologies; Venture Partners; and Genevest...
Read More
BioCentury | Jul 14, 2000
Financial News

Axovan raises $4.9 million

...in a venture financing. Investors included Life Science Investments; NMT New Medical Technologies; Venture Partners; Genevest...
Read More
Items per page:
1 - 10 of 11